Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan

Study Objectives: Diabetes mellitus per se and its related therapy have been frequently associated with an increased risk of developing dementia. However, studies that explored the risk of dementia from the use of the novel oral antidiabetic medication dipeptidyl peptidase 4 inhibitor (DPP-4i) have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Med
Hauptverfasser: Chen, Kuan-Chan, Chung, Chi-Hsiang, Lu, Chieh-Hua, Tzeng, Nian-Sheng, Lee, Chien-Hsing, Su, Sheng-Chiang, Kuo, Feng-Chih, Liu, Jhih-Syuan, Hsieh, Chang-Hsun, Chien, Wu-Chien
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141309/
https://ncbi.nlm.nih.gov/pubmed/32121372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9030660
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge